Trial Profile
Effects of aspirin +/- ximelagatran on platelet activity and inflammatory markers in patients with myocardial infarction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2011
Price :
$35
*
At a glance
- Drugs Ximelagatran (Primary) ; Aspirin
- Indications Thrombosis
- Focus Pharmacodynamics
- Acronyms ESTEEM
- 01 Sep 2011 Results published in the Journal of Internal Medicine.
- 05 Nov 2010 New trial record.